Key Insights• According to the research report, "South Africa Antacids Market Outlook, 2031," published by Actual Market Research, the South Africa Antacids Market is expected to reach a market size of more than 33.6 Million by 2031.• The demand for antacids and heartburn remedies in South Africa is driven by high rates of acid-related conditions linked to dietary habits, obesity, and stress across urban centers like Johannesburg, Cape Town, and Durban. Clinical epidemiological studies in South Africa show that the prevalence of Gastroesophageal Reflux Disease (GERD) in the adult population ranges from 27% to 40% in regional cohorts, with heartburn identified as the most common symptom affecting 49.6% of sufferers.• Market innovation centers heavily on sodium alginate paired with dual antacid neutralizers (pioneered by brands like Gaviscon Dual Action). These formulations react with gastric juice to form a physical protective raft over stomach contents while buffering excess acid, providing rapid relief against both heartburn and esophageal regurgitation. While chewable tablets generate high volume due to portability, liquid suspensions and single-serve liquid sachets represent fast-growing delivery formats in modern retail outlets due to immediate symptom onset.• The South African healthcare market features a varied distribution model where private retail pharmacy chains act as the primary touchpoint for self-medication. Retail pharmacy chains (such as Clicks and Dis-Chem) alongside independent community pharmacies account for over 65% of total OTC indigestion and antacid product sales in the country.Market Outlook• The regulatory landscape is governed by the South African Health Products Regulatory Authority (SAHPRA) and guided by the South African Gastroenterology Society (SAGES) and Self-Care Association of South Africa (Self-Care SA), with market supply led by domestic and multinational leaders including Adcock Ingram (Biomicus, Gastrolyte), Reckitt Benckiser (Gaviscon), Bayer (Rennie), Haleon (Eno), Aspen Pharmacare, and Johnson & Johnson / Kenvue.• Manufacturers are shifting production away from bulky glass liquid bottles toward convenient single-dose foil sachets and waterless chewables to cater to mobile urban consumers and commuters. Aligning with rising consumer interest in natural health, future product launches in South Africa are expected to feature hybrid formulations combining fast-acting mineral buffering agents with natural botanicals (e.g., aloe vera, ginger) to offer both immediate acid relief and gastric mucosa support.Market DynamicsDriver: Rising gastrointestinal problems and lifestyle-related digestive discomfortA key driver for South Africa's antacids market is the increasing incidence of gastrointestinal problems, supported by hectic lifestyles and dietary patterns that can contribute to indigestion and heartburn.

Euromonitor identifies rising gastrointestinal conditions as a major factor supporting digestive-remedy demand and expects antacids to remain the largest digestive-remedy category by retail value. Busy lifestyles, reliance on convenient/fast foods and irregular eating habits can increase the need for rapid, accessible symptom relief.Challenge: Price sensitivity and competition from natural/traditional alternativesA major challenge is consumer affordability and substitution from alternative approaches to digestive health. South African consumers remain price-sensitive, while some are increasingly trying to manage digestive complaints through diet, probiotics, exercise and herbal/traditional remedies rather than relying exclusively on conventional pharmaceutical products. Euromonitor specifically identifies holistic health and wellness lifestyles as a potential constraint on regular digestive-remedy use. The competitive landscape is also highly fragmented, meaning manufacturers compete across numerous brands and formulations.Trend: Shift toward herbal/traditional products and convenient liquid formatsA notable trend is the growing interest in herbal and traditional digestive remedies, alongside continued demand for convenient antacid formats. Euromonitor identifies paediatric and herbal/traditional solutions as important areas of development and sees further potential as consumers adopt more holistic approaches to digestive health.

The combination of these trends suggests that consumers are not simply moving away from pharmaceutical antacids; rather, the market is fragmenting into different use cases traditional tablets for affordability and familiarity, liquids for convenience and rapid use, and herbal/traditional products for consumers seeking more holistic solutions.Segment AnalysisSouth Africa Antacids Market By Drug Class• Acid neutralizers remain closely associated with rapid, on-demand relief because they neutralize gastric acid already present in the stomach. Aluminium hydroxide, magnesium hydroxide and calcium-containing preparations are important approaches. South African pharmacy guidance positions antacids or alginate-antacid products primarily for occasional heartburn, while also emphasizing their role as rapid relief for breakthrough symptoms.• Proton Pump Inhibitors (PPIs) occupy a more sustained acid-control position because they suppress gastric acid production rather than simply neutralizing existing acid. In South Africa, their OTC positioning is more appropriate for consumers experiencing frequent symptoms than for occasional episodes. Pharmacy guidance indicates that OTC PPI treatment should generally be limited to 14 days, after which persistent or recurrent symptoms should prompt medical referral.• H2 antagonists provide an intermediate acid-suppression option between rapid antacid relief and longer-acting PPIs. They can be useful for consumers experiencing more frequent symptoms who require acid suppression without necessarily moving immediately to a PPI.

South African OTC guidance similarly places H2-receptor antagonists within a limited-duration self-treatment framework, helping prevent prolonged unsupervised use.• Pro-motility agents represent a specialized segment because their principal function is to influence gastrointestinal movement rather than directly neutralize gastric acid. They may be relevant when reflux-like symptoms occur alongside delayed gastric emptying, post-meal fullness or other motility disturbances. Consequently, this class has a more clinically directed role than conventional OTC antacid consumption.• Combination formulations are particularly relevant where heartburn occurs together with reflux, gas or indigestion. Antacid-alginate products can combine acid neutralization with a physical barrier against reflux, while formulations containing anti-gas ingredients can address abdominal discomfort simultaneously. This multi-symptom positioning provides differentiation in South Africa's established OTC gastrointestinal category. South African pharmacy guidance specifically recognizes alginate-antacid products for occasional heartburn and breakthrough symptoms.South Africa Antacids Market By Dosage Form• Tablets and chewables are highly suited to self-care because they are portable, easy to dose and can be taken without measuring equipment.

Chewable antacids are particularly convenient for consumers experiencing symptoms after meals or while away from home. Their straightforward administration also makes them suitable for pharmacist-guided OTC selection.• Liquid suspensions provide an important alternative for consumers who have difficulty swallowing solid medicines. Aluminium- and magnesium-based liquids can accommodate different active-ingredient combinations and offer flexible dosing. However, shaking, accurate measurement, flavour and storage requirements make product design particularly important.• Powders provide a convenient non-tablet option, particularly when packaged in single-dose sachets. They can be designed for rapid dissolution or dispersion and offer good portability. Their main limitation is the additional preparation step compared with ready-to-use liquids or chewables.• Gels and syrups emphasize smooth administration and can support formulations designed around reflux-barrier mechanisms.

Alginate-containing gels are particularly distinctive because they can form a protective layer over gastric contents, providing an additional mechanism beyond acid neutralization. Syrup formulations can differentiate through flavour and ease of swallowing.• Gummies and other formats represent a newer consumer-oriented opportunity. Their appeal comes from portability, palatability and familiar administration. However, conventional antacid ingredients can require relatively high active-ingredient loading, creating formulation challenges involving taste, texture and product stability. Effervescent and rapidly dispersible products therefore offer alternative innovation opportunities.South Africa Antacids Market By Indication• Gastroesophageal Reflux Disease (GERD) is an important indication supporting South Africa's acid-control category. A 2025 study among 353 adults in Mthatha, Eastern Cape, found GERD in 32.0% of participants.

The most frequently reported GERD symptom was heartburn at 49.6%, followed by sleep disturbance at 34.8% and regurgitation at 32.3%. The findings demonstrate a substantial local burden of reflux-related symptoms, although the study population was facility-based and should not be interpreted as a national prevalence estimate.• Heartburn is one of the strongest consumer-facing indications because it is readily recognized and frequently prompts self-treatment. The Mthatha study's 49.6% heartburn prevalence among participants highlights the importance of this symptom in the local clinical setting. For occasional symptoms, rapid-relief antacids can be appropriate, while frequent or persistent heartburn may require H2 antagonists, PPIs or clinical evaluation.• Peptic ulcer represents a more medically managed indication than routine heartburn. Antacids can temporarily relieve acid-related discomfort but do not address underlying causes such as H. pylori infection or NSAID-associated mucosal injury. Consequently, PPIs and treatment directed at the underlying cause have a more important role in ulcer management, while traditional antacids remain primarily symptom-relief products.• Others include dyspepsia, acid indigestion, gastritis-related discomfort, bloating and post-meal fullness.

South African gastroenterology guidance identifies antacids as widely used OTC agents for dyspepsia and notes their usefulness for symptoms including heartburn, indigestion and bloating. This creates a broader symptom-driven market beyond formally diagnosed GERD.South Africa Antacids Market By Distribution Channel• Retail pharmacies remain strategically important because consumers can obtain OTC gastrointestinal medicines while receiving professional guidance. SAHPRA maintains an official OTC Online Medicines' Directory covering registered OTC medicines available in South Africa without a doctor's prescription. This regulatory infrastructure supports pharmacy-led consumer selection and provides a formal reference for identifying authorized OTC products.• Hospital pharmacies serve a more clinically supervised segment involving patients with diagnosed GERD, peptic ulcers, severe dyspepsia and other gastrointestinal conditions. Demand through this channel is therefore more influenced by physician diagnosis, treatment protocols and institutional medicine procurement than by spontaneous consumer purchases.• Online pharmacies / E-commerce provide convenience for repeat purchases and allow consumers to compare brands, dosage forms and pack sizes. The channel is particularly relevant to consumers who already know which gastrointestinal product they prefer.

However, product registration and authorized supply remain important because SAHPRA maintains databases of registered medicines and licensed pharmaceutical establishments.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Antacids Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Drug Class• Acid Neutralizers• Proton Pump Inhibitors (PPIs)• H2 Antagonists• Pro-Motility Agents• Combination FormulationsBy Dosage Form• Tablets & Chewables• Liquid Suspensions• Powders• Gels & Syrups• Gummies & OtherBy Indication• Gastroesophageal Reflux Disease• Heartburn• Peptic Ulcer• OthersBy Distribution Channel• Retail Pharmacies• Hospital Pharmacies• Online Pharmacies / E-Commerce.